Recent technological advances have opened valuable possibilities for supporting people with motor impairments or who are ...
Genes associated with male reproductive biology appear to be under relaxed selective constraint in a primate species with low sperm competition.
AMG has done a lot with the CLE to make it truly special, providing satisfaction to lovers of driving, style, opulence, and ...
For almost every PC or Mac user, a keyboard and either a mouse or a trackpad are more than enough to navigate these systems without too many problems. In fact, it might be a bit too easy — people are ...
Duchenne muscular dystrophy (DMD) is caused by a mutation in the DMD gene that prevents dystrophin production, leading to progressive muscle weakness and early mobility challenges. The 2018 DMD ...
This study reveals abnormal iron accumulation in the muscles of patients with Facioscapulohumeral Muscular Dystrophy (FSHD) and in mice expressing muscle-specific DUX4 (DUX4-Tg mice). Contrary to ...
The least-squares mean difference in the Hammersmith Functional Motor Scale-Expanded change from baseline at 12 months was 1.8 points for those 2 to 12 years receiving apitegromab vs placebo.
For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhibits myostatin activation, improves motor function versus placebo, according to a ...
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...
Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results